Your browser doesn't support javascript.
loading
Targeting UPR branches, a potential strategy for enhancing efficacy of cancer chemotherapy.
Yu, Mengchao; Lun, Jie; Zhang, Hongwei; Wang, Lei; Zhang, Gang; Zhang, Haisheng; Fang, Jing.
Afiliação
  • Yu M; Cancer Institute, The Affiliated Hospital of Qingdao University, Cancer Institute of Qingdao University, Qingdao 266061, China.
  • Lun J; Cancer Institute, The Affiliated Hospital of Qingdao University, Cancer Institute of Qingdao University, Qingdao 266061, China.
  • Zhang H; Oncology Department, Shandong Provincial Maternal and Child Health Care Hospital, Jinan 250014, China.
  • Wang L; Cancer Institute, The Affiliated Hospital of Qingdao University, Cancer Institute of Qingdao University, Qingdao 266061, China.
  • Zhang G; Cancer Institute, The Affiliated Hospital of Qingdao University, Cancer Institute of Qingdao University, Qingdao 266061, China.
  • Zhang H; Center for Cancer Targeted Therapies, Signet Therapeutics Inc., Research Institute of Tsinghua University in Shenzhen, Shenzhen 518057, China.
  • Fang J; Cancer Institute, The Affiliated Hospital of Qingdao University, Cancer Institute of Qingdao University, Qingdao 266061, China.
Acta Biochim Biophys Sin (Shanghai) ; 53(11): 1417-1427, 2021 Nov 10.
Article em En | MEDLINE | ID: mdl-34664059

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases / Resistencia a Medicamentos Antineoplásicos / EIF-2 Quinase / Endorribonucleases / Fator 6 Ativador da Transcrição / Resposta a Proteínas não Dobradas / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases / Resistencia a Medicamentos Antineoplásicos / EIF-2 Quinase / Endorribonucleases / Fator 6 Ativador da Transcrição / Resposta a Proteínas não Dobradas / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article